11th Meet The Professor

Advanced International Breast Cancer Course (AIBCC)

Padua, September 10th - 12th, 2015



  • Aims
  • Directors
  • Scientific Committee
  • Speakers
  • Preliminary Program
  • Registration

Breast cancer represents the front runner in cancer research in many aspects. First, this is a common, chronic and lethal disease where medical interventions are successfully inducing a continuous decline in mortality in spite of increasing incidence. Second, biology drives the entire diagnostic-therapeutic work up of these patients. This is why, nowadays, a breast multidisciplinary team should also include pathologists, molecular biologists, oncogeneticists besides the “classic” clinical specialties. Third, many highly effective interventions are available for each step of the diagnostic and therapeutic work-up of these patients. The increased complexity of the disease, the availability of multiple effective choices and the high expectations of our patients are raising the bar of clinical excellence in this field.

With this goal in mind, the Programme of this international Conference includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes.

Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.

This 11th Breast Cancer Conference includes a highly qualified international faculty, but will maintain its characteristics of a friendly forum where international opinion leaders and attendees will exchange experiences and share the most exiting advances.

In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 11th AIBCC will award the 5th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year.

We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere.

Addressed to

Oncologists, pathologists, radiologists, radiation oncologists, surgeons, gynaecologists, biologists and nurses.

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

Award

UNIVERSITY OF PADUA AWARD FOR ADVANCES IN BREAST CANCER 2015

The Scientific Committee will select young researchers (< 40 years from any country) who have published in an international peer-reviewed journal, as the principal author, a manuscript reporting important clinical or biological advances in breast cancer. Prof. Conte and Prof. Hortobagyi will select the final winner which will be invited to present his/her study during the annual Conference

Ecm

Based on the in force regulations approved by the CNFC, Accademia Nazionale di Medicina (provider n. 31) will request the MCE Accreditation.

The Meeting is addressed to physicians specialized in oncology, radiodiagnostics, radiotherapy, clinical pathology, general surgery, gynaecology and obstetrics, biologists and nurses. It will not be possible to give credits to physicians specialized in different fields.

The credit certification is subject to:

  • attendance at the entire Meeting
  • the completion of the Meeting evaluation form
  • the completion of the final questionnaire (at least 75% of correct answers)

We would like to remind you to participants that only 1/3 of CME credits acquired during the years 2014/2016 can come from a sponsorship.

Foto

Pier Franco Conte

Division of Medical Oncology 2

Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology
and Gastroenterology
University of Padua (I)

Foto

Gabriel N. Hortobagyi

Department of Breast Medical Oncology

The University of Texas - MD Anderson Cancer Center
Houston (USA)

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Hesham Ahmed Gaballah Elghazaly

Department of Clinical Oncology and nuclear medicine
University of Ainshams
Cairo (EG)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Sibylle Loibl

German Breast Group
Department of Medicine and Research
University of Frankfurt (D)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Marañon
Madrid (S)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Radbound University Medical Centre
Nijmegen (NL)

Alberto Amadori

Division of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Riccardo Audisio

Department of Surgery
St Helens Teaching Hospital
Liverpool (UK)

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Giampaolo Bianchini

Department of Medical Oncology
San Raffaele Hospital
Milan

Francois-Clement Bidard

Cancer Foundation
Curie Institute
Paris (F)

Fernando Bozza

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Marco Colleoni

Division of Medical Senology
European Institut of Oncology (IEO)
Milan (I)

Pier Franco Conte

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Alessandro Coran

Breast Imaging Unit
Istituto Oncologico Veneto IRCCS
Padua (I)

Lucia Del Mastro

Medical Oncology A- Innovative therapies development
National Institute for Cancer Research
Genoa (I)

Maria Vittoria Dieci

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Hesham Ahmed Gaballah Elghazaly

University of Ainshams
Department of Clinical Oncology and Nuclear Medicine
Il Cairo (E)

Carlos A. Garcia-Etienne

Division of Breast Surgery
S. Matteo Hospital
Pavia (I)

Alessandra Gennari

Department of Medical Oncology
Galliera Hospital
Genova (I)

Salvatore Gizzo

Department of Gynecology and Obstetrics
University Hospital
Padua (I)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Gabriel N. Hortobagyi

Department of Breast Medical Oncology
The University of Texas - MD Anderson Cancer Center
Houston (USA)

Claude Houdayer

Department de Biologie des Tumeurs - Service Genetique
Institut Curie Paris (F)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Sibylle Loibl

German Breast Group
Department of Medicine and Research
University of Frankfurt (D)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Marañon
Madrid (S)

Giovanna Masala

Institute of Oncology Prevention and Studies
Florence (I)

Marco Montagna

Hereditary Tumors Group Breast and Ovary Cancer
Department of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Giovanni Battista Nardelli

Department of Gynecology and Obstetrics
University Hospital
Padova (I)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Enrico Orvieto

General Pathology & Cytopathology Unit
Department of Medicine-DIMED University of Padua (I)
Padova (I)

Fedro Peccatori

Department of Medical Oncology
European Institute of Oncology
Milan (I)

Luigi Pescarini

Department of Radiology
Diagnostic Breast Unit
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Ilaria Polico

Breast Imaging Unit
Istituto Oncologico Veneto IRCCS
Padua (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Radbound University Medical Centre
Nijmegen (NL)

Aleix Prat

Institute of Oncology (VHIO)
Vall d’Hebron
Barcellona (E)

Massimo Rugge

General Pathology & Cytopathology Unit
Department of Medicine-DIMED
University of Padua (I)

Tania Saibene

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Peter Schmid

Centre for Experimental Cancer Medicine
Bart Cancer Institute
Queen Mary University
London (GB)

Corrado Tinterri

Depatment of Senology
Humanitas Clinical Institute
Rozzano - MI)

Andrew Tutt

Breast Cancer Research Unit
Kings College
London (GB)

Giuseppe Viale

Department of Pathology
European Institute of Oncology
University of Milan (I)

Manuel Zorzi

Cancer Registry of Veneto
Padova (I)

Thursday, September 10th

8.00

Registration

 

8.45

Introduction to the Conference

Pier Franco Conte, Gabriel N. Hortobagyi

 

SESSION I-LIFE STYLE AND BREAST CANCER

Chairmen: Gabriel N. Hortobagyi, Manuel Zorzi

9.00

Prevention of breast cancer with life style changes and drugs

Alessandra Gennari

9.20

Life style after breast cancer diagnosis

Giovanna Masala

9.40

Fertility and breast cancer

Fedro Peccatori

10.00

Q&A

 

10.30

Coffee break

 

 

SESSION II-GENETIC TESTING

Chairmen: Alberto Amadori, Sibylle Loibl

11.00

BRCA: from genetic to predictive test

Andrew Tutt

11.30

BRCA: germline versus somatic mutations

Claude Houdayer

12.00

In and around the BRCA genes: the clinical relevance of variants of unknown significance and genetic modifiers

Marco Montagna

12.30

Multiplex germline mutation assays: ready for clinical use?

Gabriel N. Hortobagyi

13.00

Q&A

 

13.15

Lunch

 

 

SESSION III-PATHOLOGY AND GENOMICS

Chairman: Gabriel N. Hortobagyi

14.15

“Liquid biopsy”: CTCs, ctDNA, microRNA – Ready for prime time?

Francois Clement Bidard

14.45

Clinical validity versus clinical utility of genomic tests

Aleix Prat

15.15

Discordant pathology and genomic data: what should drive the therapeutic choice?

Giuseppe Viale

15.45

Q&A

 

16.00

Coffee break

 

 

CUP syndrome– Clinical Case Discussion I

Chairmen: Fernando Bozza, Pier Franco Conte

16.30

CUP cases will be presented and the audience will be asked to vote on different options

resenter of the cases: Maria Vittoria Dieci

17.10

A panel composed by pathologists, radiologists, surgeons and medical oncologists will discuss the votes of the audience and express their opinions

Hesham Ahmed Gaballah Elghazaly, Carlos A. Garcia-Etienne, Gabriel N. Hortobagyi, Sibylle Loibl, Luigi Pescarini, Philip Poortmans, Corrado Tinterri

18.00

Adjourn

 

Friday, September 11th

 

Imaging – Clinical Case Discussion II

Chairmen: Pier Franco Conte, Luigi Pescarini

8.30

Problematic/difficult cases of breast imaging will be presented. The presenters will ask the audience to express their opinion (voting system)

Presenters of the cases: Alessandro Coran, Ilaria Polico

8.50

A panel composed by radiologists, surgeons and clinicians will express their opinions and comment on the audience voting

Riccardo Audisio, Hesham Ahmed Gaballah Elghazaly, Carlos A. Garcia- Etienne, Gabriel N. Hortobagyi, Luigi Pescarini, Philip Poortmans, Corrado Tinterri

 

Axillary Staging – Clinical Case Discussion III

Chairmen: Pier Franco Conte, Massimo Rugge

9.30

Cases of early breast cancer patients will be presented: extensive DCIS without infiltrating carcinoma, DCIS with multiple micro-filtrating foci, infiltrating carcinoma with micrometastatic SN, infiltrating carcinoma with different biologies with macrometastatic SN. The audience will be asked to vote on different options

Presenter of the cases: Tania Saibene

9.50

A panel composed by pathologists, surgeons, medical and radiation oncologists will discuss the votes of the audience and express their opinion

Riccardo Audisio, Pier Franco Conte, Hesham Ahmed Gaballah Elghazaly, Carlos A.Garcia-Etienne Gabriel N. Hortobagyi, Sybille Loibl, Enrico Orvieto, Philip Poortmans, Corrado Tinterri, Giuseppe Viale

10.30

Coffee break

 

 

SESSION IV-SURGERY & RADIOTHERAPY

Chairmen: Sibylle Loibl, Donato Nitti

11.00

Oncoplastic surgery: opportunities and challenges

Riccardo Audisio

11.30

Risk reducing surgery: role in BRCAmut and BRCAwt patients

Corrado Tinterri

12.00

Update on radiation therapy (hypofractionation, boost, IORT, postmastectomy radiotherapy)

Philip Poortmans

12.30

Q&A

 

12.45

Lunch

 

 

SESSION V –PREMENOPAUSAL EARLY BREAST CANCER

Chairman: Gabriel N. Hortobagyi

13.45

Management of very young patients

Sibylle Loibl

14.15

Adjuvant endocrine therapy after SOFT and TEXT trials

Marco Colleoni

14.45

Management of endocrine and sexual problems in young patients

Giovanbattista Nardelli, Salvatore Gizzo

15.15

Pregnancy after breast cancer

Lucia Del Mastro

15.45

Q&A

 

17.30

Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2014

 

18.00

Lecture of the Awardee

 

18.30

Cocktail

The Ceremony and the cocktail will take place in palazzo Bo, Via VIII Febbraio 2, Padua

Saturday, September 12th

 

SESSION VI – NEW THERAPEUTIC ALGORITHMS FOR ABC PATIENTS

Chairmen: Pier Franco Conte, Gabriel N. Hortobagyi

9.00

HR+ ABC

Stephen Johnston

9.30

HER2+ ABC

Valentina Guarneri

10.00

Triple negative advanced breast cancer

Miguel Martin

11.00

Coffee break

 

11.30

Immunity and triple negative breast cancer

Peter Schmid

12.00

Immunity and HER2+ BC

Gianpaolo Bianchini

12.30

From development to access: how to harmonise sustainability, equanimity an innovation

Jonas Bergh

13.00

Q&A

 

13.30

Adjourn and final evaluation questionnaire

 

Registration Fee

€ 250,00

Tax free.

It includes the conference bag, the conference book and all coffee breaks and lunches. It does not include Hotel accomodation, dinners and travel expenses.

Registrazione consentita fino al giorno 20/04/2015.


Under 35

Free admission is available for 5 persons “under 35”. Registration forms will be accepted on a first-come, first-served basis unitil spaces are filled. The Organization Secretariat will confirm the registration by email.

Meeting Venue

Centro Congressi Padova A. Luciani, Via Forcellini 170/A, Padova.
+39.049.803.37.11

 

How to reach the meeting venue